Lunit Inc., a leading provider of AI-powered cancer diagnostics and treatments, has announced a renewed partnership with Cloud Solutions, a division of Dr. Sulaiman Al Habib Medical Group, the largest healthcare organization in Saudi Arabia. Building on their successful collaboration in 2023, the new agreement will see Lunit provide its AI-driven chest X-ray analysis tool, Lunit INSIGHT CXR, to Saudi Arabia for the next three years, with the technology set to analyze around 1 million chest X-ray images.
This recent agreement extends the initial partnership between Lunit and HMG, which saw the introduction of Lunit INSIGHT MMG to aid in breast cancer screening across the Kingdom (TADAWUL:4280). The addition of Lunit INSIGHT CXR to the collaboration is intended to improve diagnostic accuracy and efficiency in identifying critical chest conditions, including lung cancer, tuberculosis, and pneumonia.
Brandon Suh, CEO of Lunit, expressed pride in strengthening the collaboration with Dr. Sulaiman Al Habib Medical Group. He emphasized that the second contract highlights the importance of their AI solutions and mirrors the mutual dedication to enhancing healthcare through innovation.
Lunit INSIGHT CXR leverages advanced AI technology to detect chest abnormalities with exceptional accuracy, enabling faster and more precise diagnoses while enhancing clinical workflows. This technology aligns with Saudi Arabia’s Vision 2030, which emphasizes innovation and digital transformation in healthcare.
As per Markets and Data, Saudi Arabia’s AI-driven medical diagnostics market is projected to grow at a compound annual growth rate (CAGR) of 26.97%, expanding from $34.37 million in 2023 to $231.77 million by 2031. The new contract strengthens Lunit's presence in a region poised for rapid adoption of AI-based healthcare solutions.
